Cite
APA Citation
Berni, E., Poole, C., Conway, P., Radwan, A., & Currie, C. (n.d.). pWE-095 Cost effectiveness of rifaximin-α 550 mg (xifaxan®/targaxan®) in the reduction of recurrence of overt hepatic encephalopathy in united kingdom. Gut, 64, A253–A254. http://access.bl.uk/ark:/81055/vdc_100135552375.0x000047